BMJ 2016 Mar 2
A (relatively) risky business: the link between prostatic radiotherapy and second malignancies.   

Related Questions

Assume a young, fit patient who has not had prior pelvic RT before, and has been fully staged with molecular imaging (e.g., PSMA) with no evidence of ...